Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Axetis Inert Coronary Stent System First In Man Clinical Investigation (AXETIS FIM)

NCT02317081 is registered in ClinicalTrials.gov with Axetis AG as lead sponsor.

NCT NCT02317081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02317081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Axetis Inert Coronary Stent System First In Man Clinical Investigation (AXETIS FIM)
Lead sponsor
Axetis AG
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2014
Completion date
July 31, 2017
Enrollment
35 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

native coronary artery stenosis